Generics News

First Generic Ortho Evra Patch Launched

Mylan announced that it has launched Xulane (Norelgestromin/Ethinyl Estradiol Transdermal System) 150/35mcg per day, the generic version of Janssen's Ortho Evra transdermal patch.

Impax Launches Generic Renvela

Impax Laboratories announced the launch of Sevelamer Carbonate Tablets, the generic version of Genzyme's Renvela.

Dr. Reddy's Launches Generic Lunesta

Dr. Reddy's Laboratories announced the launch of Eszopiclone Tablets (C-IV), the generic version of Sunovion's Lunesta.

Generic Lunesta Now Available

Mylan announced it has received final approval from the FDA for its ANDA of Eszopiclone Tablets, the generic version of Sunovion's Lunesta.

Lannett Launches Generic Diazepam Intensol

Lannett Company announced it has received FDA approval for its Abbreviated New Drug Application (ANDA) for Diazepam Oral Solution (Concentrate), the generic of Roxane's Diazepam Intensol.

Teva Launches Generic Lovaza

Teva Pharmaceuticals announced the launch of Omega-3-Acid Ethyl Esters Capsules, USP, a generic version of GlaxoSmithKline's Lovaza.

Newly Approved Ophthalmic Phenylephrine HCl Available

Paragon BioTeck announced it has received FDA approval for Phenylephrine HCl Ophthalmic Solution, USP, to dilate the pupil.

Par Launches Potassium Chloride ER Caps

Par announced it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Potassium Chloride Extended-Release (ER) Capsules.

Teva Launches Generic Evista

Teva announced the launch of Raloxifene Hydrochloride Tablets, the generic version of Eli Lilly's Evista.

Sandoz Launches Generic Taclonex Ointment

Sandoz announced the launch of Calcipotriene and Betamethasone Dipropionate Ointment, the generic version of Leo Pharma's Taclonex Ointment.